About Triera Biosciences
Triera Biosciences is working to accelerate innovation in the biomanufacturing and life sciences industry worldwide. Triera is a Canadian biosciences company that is developing an aptamer therapeutics platform in partnership with McMaster University. Aptamers are synthetic single-stranded DNA- or RNA-type molecules that are built from the same building blocks of human DNA or RNA. They can selectively bind to a target with high affinity and specificity, making them ideally suited for detection and treatment applications Triera is owned by Zentek Ltd., a publicly traded nanotechnology development and commercialization company based out of Canada.
- Employees
- 1 to 10
- Headquarters
- Canada
Leadership
The top of Triera Biosciences's org chart, with how many people report into each leader.
Colin van der Kuur
Interim Chief Scientific Officer
Jobs at Triera Biosciences
No open positions right now. Explore more companies on TheJobsMap.